Last reviewed · How we verify

NCT06612021

Hema Free Versus Hema Containing Adhesives in Posterior Restorations

Active, enrolled NA Last updated 25 September 2024
What this trial tests

NA trial testing Beautibond universal adhesive in Dental Caries in 64 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
14 July 2023
Primary endpoint
14 October 2024
1 November 2024

Quick facts

Lead sponsorCairo University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment64
Start date14 July 2023
Primary completion14 October 2024
Estimated completion1 November 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 19 to 35, any sex, with Dental Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of study is to evaluate the clinical performance of posterior restorations using HEMA free universal adhesive versus HEMA containing universal adhesive over one year using USPHS criteria.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dental Caries

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06612021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing